Literature DB >> 11251186

Physical interaction between p53 and primary response gene Egr-1.

J Liu1, L Grogan, M M Nau, C J Allegra, E Chu, J J Wright.   

Abstract

The tumor suppressor p53 and primary response gene Egr-1 are nuclear transcription factors with regulatory roles in signal transduction pathways mediating cellular proliferation and growth arrest as well as the complex genetic programs controlling differentiation and programmed cell death. We identified a physical association between these regulatory proteins in vitro and in vivo. Recombinant p53 and Egr-1 fusion proteins complexed with in vitro translates of Egr-1 or p53, respectively, or with these respective proteins in cell lysates. This protein-protein interaction was detected in vivo by immunoprecipitation and Western blot analysis of serum-activated cellular lysates with high levels of induced Egr-1 and of human lung cancer cell lines with constitutive overexpression of Egr-1 and mutant p53. A p53 mutant at codon 154 did not bind Egr-1, while p53 proteins with point mutations at residues 156, 246, 247, and 273 associated with this zinc finger transcription factor. p53 bound full-length Egr-1 and an Egr-1 mutant with a deletion of the 5' transactivation region but did not associate with Egr-1 protein lacking an internal segment that included the first two zinc finger domains, suggesting that binding may require the presence of intact zinc finger motifs. A variant-sized Egr-1 protein expressed by lung fibroblast cell line MRC-9 was also bound by p53. The interaction of these regulatory proteins may alter multiple features of their biological activity especially with regard to the specificity of transcriptional control.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251186     DOI: 10.3892/ijo.18.4.863

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  25 in total

1.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

Review 2.  Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations.

Authors:  Asfar S Azmi; Zhiwei Wang; Philip A Philip; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Mol Cancer Ther       Date:  2010-11-01       Impact factor: 6.261

3.  Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain.

Authors:  Yifan Lu; Tong Li; Hamid Y Qureshi; Dong Han; Hemant K Paudel
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

4.  Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence.

Authors:  Anja Krones-Herzig; Eileen Adamson; Dan Mercola
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 5.  Friend or foe, the role of EGR-1 in cancer.

Authors:  Tong-Tong Li; Man-Ru Liu; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2019-11-20       Impact factor: 3.064

Review 6.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Authors:  V Baron; E D Adamson; A Calogero; G Ragona; D Mercola
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

7.  Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Karen M Henkels; William C Grunwald; David Cool; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2011-11-17       Impact factor: 5.157

8.  PTEN regulation by Akt-EGR1-ARF-PTEN axis.

Authors:  Jianxiu Yu; Sharon S Zhang; Kan Saito; Scott Williams; Yutaka Arimura; Yuliang Ma; Yuehai Ke; Veronique Baron; Dan Mercola; Gen-Sheng Feng; Eileen Adamson; Tomas Mustelin
Journal:  EMBO J       Date:  2008-12-04       Impact factor: 11.598

9.  Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression.

Authors:  Eva L Decker; Nina Nehmann; Eva Kampen; Hermann Eibel; Peter F Zipfel; Christine Skerka
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

10.  The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice.

Authors:  Magdalena L Bochenek; Tobias Bauer; Rajinikanth Gogiraju; Yona Nadir; Amrit Mann; Tanja Schönfelder; Leonie Hünig; Benjamin Brenner; Thomas Münzel; Philip Wenzel; Stavros Konstantinides; Katrin Schäfer
Journal:  Blood Adv       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.